Haoxi Health Technology (HAO) is trading down at $2.64 (-2.41%), as of the latest quote. It operates in the Industrials sector.
| FY2022Jun 2022 | FY2023Jun 2023 | FY2024Jun 2024 | FY2025Jun 2025 | FY2026Jun 2026 | |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $16.2M | $28.2M | $48.5M | $32.8M | $54.8M |
| Growth (year over year) | — | +74.7% | +71.9% | −32.4% | +67.1% |
| Gross profit | $648.7K | $2.06M | $2.75M | $927.8K | $629.1K |
| Gross margin | 4.0% | 7.3% | 5.7% | 2.8% | 1.1% |
| Operating income | $268.8K | $1.20M | $1.72M | −$2.00M | −$9.66M |
| Operating margin | 1.7% | 4.2% | 3.5% | −6.1% | −17.6% |
| Net income | $244.6K | $969.8K | $1.29M | $3.88M | −$9.54M |
| Net margin | 1.5% | 3.4% | 2.7% | 11.8% | −17.4% |
| EPS (diluted) | $0.01 | $0.87 | $2701.53 | $3385.53 | −$386.40 |
| Balance sheet | |||||
| Cash and equivalents | $293.5K | $1.20M | $6.66M | $8.62M | $10.9M |
| Total assets | — | $4.46M | $15.5M | $21.6M | $21.6M |
| Total liabilities | — | $2.90M | $4.23M | $4.22M | $3.71M |
| Long-term debt | — | $249.1K | $301.7K | $307.3K | — |
| Shareholders' equity | −$1.47M | $1.57M | $11.3M | $17.4M | $17.9M |
| Cash flow | |||||
| Operating cash flow | −$675.4K | −$872.1K | −$747.6K | −$3.36M | −$2.57M |
| Capital expenditure | $8.70K | $45.5K | $55.4K | — | — |
| Free cash flow | −$684.1K | −$917.6K | −$802.9K | — | — |
From Haoxi Health Technology's 20-F and 6-K filings with the SEC; its fiscal year ends in June. Each period shows the latest figure the company has reported for it, including restatements. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. Filings on SEC EDGAR →
No recent news mentioning Haoxi Health Technology in our feed yet.